S&P 500   2,992.55 (-0.18%)
DOW   26,841.10 (-0.68%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
BABA   170.36 (-3.67%)
GE   8.99 (-0.55%)
TSLA   256.90 (-1.94%)
AMD   30.81 (-1.06%)
F   9.29 (+1.98%)
GILD   64.23 (-1.53%)
S&P 500   2,992.55 (-0.18%)
DOW   26,841.10 (-0.68%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
BABA   170.36 (-3.67%)
GE   8.99 (-0.55%)
TSLA   256.90 (-1.94%)
AMD   30.81 (-1.06%)
F   9.29 (+1.98%)
GILD   64.23 (-1.53%)
Log in

Align Technology Stock Price, News & Analysis (NASDAQ:ALGN)

$214.45
+0.53 (+0.25 %)
(As of 10/18/2019 03:00 PM ET)
Today's Range
$210.35
Now: $214.45
$216.29
50-Day Range
$171.92
MA: $184.00
$214.26
52-Week Range
$169.84
Now: $214.45
$334.64
Volume43,476 shs
Average Volume1.17 million shs
Market Capitalization$17.13 billion
P/E Ratio43.59
Dividend YieldN/A
Beta2
Align Technology, Inc, a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontics, and restorative and aesthetic dentistry worldwide. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as compliance indicators and compensation for tooth eruption; Invisalign Assist treatment, which offers support to dental practitioners throughout the treatment process, including progress tracking; and Invisalign First Phase I and Invisalign First Comprehensive Phase II package for younger patients with early mixed dentition with a mixture of primary/baby and permanent teeth. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ALGN
CUSIP01625510
Phone408-470-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.97 billion
Cash Flow$5.83 per share
Book Value$15.66 per share

Profitability

Net Income$400.23 million

Miscellaneous

Employees11,660
Market Cap$17.13 billion
Next Earnings Date10/23/2019 (Confirmed)
OptionableOptionable

Receive ALGN News and Ratings via Email

Sign-up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.


Align Technology (NASDAQ:ALGN) Frequently Asked Questions

What is Align Technology's stock symbol?

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) released its quarterly earnings results on Wednesday, July, 24th. The medical equipment provider reported $1.26 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.13 by $0.13. The medical equipment provider had revenue of $600.70 million for the quarter, compared to analysts' expectations of $599.86 million. Align Technology had a return on equity of 29.26% and a net margin of 19.06%. The company's revenue was up 22.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.30 earnings per share. View Align Technology's Earnings History.

When is Align Technology's next earnings date?

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for Align Technology.

How can I listen to Align Technology's earnings call?

Align Technology will be holding an earnings conference call on Wednesday, October 23rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Align Technology issued on next quarter's earnings?

Align Technology issued an update on its third quarter earnings guidance on Wednesday, July, 24th. The company provided EPS guidance of $1.09-1.16 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.45. The company issued revenue guidance of $585-600 million, compared to the consensus revenue estimate of $623.83 million.

What price target have analysts set for ALGN?

13 analysts have issued twelve-month price targets for Align Technology's stock. Their predictions range from $200.00 to $420.00. On average, they anticipate Align Technology's share price to reach $272.60 in the next year. This suggests a possible upside of 27.2% from the stock's current price. View Analyst Price Targets for Align Technology.

What is the consensus analysts' recommendation for Align Technology?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Align Technology.

Has Align Technology been receiving favorable news coverage?

News stories about ALGN stock have been trending neutral this week, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Align Technology earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave media coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Align Technology.

Are investors shorting Align Technology?

Align Technology saw a decrease in short interest in September. As of September 30th, there was short interest totalling 3,910,000 shares, a decrease of 6.7% from the August 30th total of 4,190,000 shares. Based on an average daily volume of 1,410,000 shares, the short-interest ratio is currently 2.8 days. Currently, 5.4% of the company's shares are sold short. View Align Technology's Current Options Chain.

Who are some of Align Technology's key competitors?

What other stocks do shareholders of Align Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), Adobe (ADBE), Micron Technology (MU), Paypal (PYPL), Visa (V), salesforce.com (CRM), Mastercard (MA) and Boeing (BA).

Who are Align Technology's key executives?

Align Technology's management team includes the folowing people:
  • Mr. Joseph M. Hogan, Pres, CEO & Director (Age 62)
  • Mr. John F. Morici, CFO & Sr. VP of Global Fin. (Age 52)
  • Mr. Stuart Hockridge, Sr. VP of Global HR (Age 47)
  • Mr. Raphael S. Pascaud, Sr. VP of Bus. Devel. & Strategy (Age 47)
  • Mr. Emory M. Wright, Sr. VP of Global Operations (Age 49)

Who are Align Technology's major shareholders?

Align Technology's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.11%), Commerzbank Aktiengesellschaft FI (0.06%), Gateway Investment Advisers LLC (0.04%), Nisa Investment Advisors LLC (0.04%), CIBC Private Wealth Group LLC (0.03%) and McCollum Christoferson Group LLC (0.02%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler and Yuval Shaked. View Institutional Ownership Trends for Align Technology.

Which institutional investors are selling Align Technology stock?

ALGN stock was sold by a variety of institutional investors in the last quarter, including Gateway Investment Advisers LLC, Meeder Asset Management Inc., Envestnet Asset Management Inc., Nisa Investment Advisors LLC, Pennsylvania Trust Co, Advisor Partners LLC, Wealthfront Advisers LLC and CIBC Private Wealth Group LLC. Company insiders that have sold Align Technology company stock in the last year include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Greg J Santora, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Sreelakshmi Kolli, Warren S Thaler and Yuval Shaked. View Insider Buying and Selling for Align Technology.

Which institutional investors are buying Align Technology stock?

ALGN stock was acquired by a variety of institutional investors in the last quarter, including Commerzbank Aktiengesellschaft FI, Heritage Investors Management Corp, Intellectus Partners LLC, Foundations Investment Advisors LLC, Summit Creek Advisors LLC, Pacer Advisors Inc., SeaCrest Wealth Management LLC and State of Alaska Department of Revenue. Company insiders that have bought Align Technology stock in the last two years include Joseph M Hogan and Vamsi Mohan Raj Pudipeddi. View Insider Buying and Selling for Align Technology.

How do I buy shares of Align Technology?

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Align Technology's stock price today?

One share of ALGN stock can currently be purchased for approximately $214.25.

How big of a company is Align Technology?

Align Technology has a market capitalization of $17.11 billion and generates $1.97 billion in revenue each year. The medical equipment provider earns $400.23 million in net income (profit) each year or $4.92 on an earnings per share basis. Align Technology employs 11,660 workers across the globe.View Additional Information About Align Technology.

What is Align Technology's official website?

The official website for Align Technology is http://www.aligntech.com/.

How can I contact Align Technology?

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]


MarketBeat Community Rating for Align Technology (NASDAQ ALGN)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  652 (Vote Outperform)
Underperform Votes:  461 (Vote Underperform)
Total Votes:  1,113
MarketBeat's community ratings are surveys of what our community members think about Align Technology and other stocks. Vote "Outperform" if you believe ALGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: Cost of Debt

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel